Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about SETX: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
SETX is a gene implicated in neurodegeneration research. Key relationships include: associated with, activates, inhibits. Associated with ALS, Als, Als4. Connected to 128 entities in the SciDEX knowledge graph.
| Gene Symbol | SETX |
| Full Name | Senataxin |
| Aliases | SETX gene |
| Chromosome | 9q34.13 |
| Protein Type | Enzyme |
| Target Class | Enzyme |
| Function | The SETX gene encodes a protein belonging to the superfamily 1 helicases with both ATP-dependent DNA and RNA helicase activity[@suraweera2009]. |
| Mechanism of Action | Therapeutic agents targeting SETX would likely enhance RNA helicase activity or stabilize protein function to improve transcriptional regulation and DNA repair, or alternatively inhibit aberrant signaling pathways triggered by SETX dysfunction in neuronal tissues. Small molecule stabilizers or gene therapy approaches could restore deficient helicase activity in ataxia-causing mutations. |
| Primary Expression | Brain, Spinal cord, Testis, Liver |
| Druggability | Low (0.28) |
| Clinical Stage | Approved |
| Molecular Weight | 303 kDa |
| Amino Acids | 2678 aa |
| Pathways | Autophagy, Dna Damage Response, Haploinsufficiency, Rna/Dna Helicase Activity |
| UniProt ID | Q9UH73 |
| NCBI Gene ID | 23067 |
| Ensembl ID | ENSG00000112297 |
| OMIM | 604465 |
| GeneCards | SETX |
| Human Protein Atlas | SETX |
| Associated Diseases | ALS, ALS4, AOA2, Amyotrophic Lateral Sclerosis |
| Known Drugs/Compounds | Rna, Dna, R-loop, siRNA, Sirna, rapamycin |
| Interactions | TDP1, PNKP, FEN1, XPF, XRCC1, ALS4 |
| SciDEX Target | View Target Profile (2 clinical trials) |
| SciDEX Hypotheses | R-Loop Resolution Enhancement Therapy |
| KG Connections | 412 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
SETX["SETX"]
SETX -->|"activates"| Cancer["Cancer"]
SETX -->|"activates"| Als["Als"]
SETX -->|"expressed in"| Ms["Ms"]
SETX -->|"inhibits"| Amyotrophic_Lateral_Sclerosis["Amyotrophic Lateral Sclerosis"]
SETX -->|"target for"| Stroke["Stroke"]
SETX -->|"activates"| ALS["ALS"]
h_c463d225["h-c463d225"] -->|"target for"| SETX
XPG["XPG"] -->|"activates"| SETX
ALS4["ALS4"] -->|"inhibits"| SETX
XPF["XPF"] -->|"activates"| SETX
PNKP["PNKP"] -->|"activates"| SETX
TDP1["TDP1"] -->|"activates"| SETX
FEN1["FEN1"] -->|"activates"| SETX
DNA["DNA"] -->|"activates"| SETX| Target | Relation | Type | Str |
|---|---|---|---|
| Amyotrophic Lateral Sclerosis Type 4 | causes | disease | 0.95 |
| Als4 | causes | disease | 0.95 |
| Ataxia With Oculomotor Apraxia Type 2 | causes | disease | 0.95 |
| ALS4 | causes | disease | 0.95 |
| R-Loops | mediates | compound | 0.95 |
| AOA2 | causes | disease | 0.95 |
| R-Loop | regulates | process | 0.95 |
| Macroautophagy | regulates | pathway | 0.95 |
| Amyotrophic Lateral Sclerosis 4 | causes | disease | 0.95 |
| Rna/Dna Helicase Activity | involved_in | mechanism | 0.93 |
| Rna/Dna Helicase Activity | mediates | process | 0.93 |
| m6A modification | activates | process | 0.92 |
| Amyotrophic Lateral Sclerosis | implicated_in | disease | 0.92 |
| R-loop | involved_in | process | 0.90 |
| Rna | binds | compound | 0.90 |
| Dna | binds | compound | 0.90 |
| AOA2 | associated_with | disease | 0.90 |
| Motor Neuron Degeneration | involved_in | phenotype | 0.90 |
| R-Loop Structures | involved_in | mechanism | 0.90 |
| amyotrophic lateral sclerosis type 4 | implicated_in | disease | 0.90 |
| R-Loop | interacts_with | mechanism | 0.90 |
| AUTOPHAGY GENES | upregulates | gene | 0.90 |
| dominant mutation | causes | mutation | 0.90 |
| M6A Regulators | activates | protein | 0.90 |
| RNA/DNA Helicase Activity | mediates | process | 0.88 |
| Motor Neuron Function | involved_in | process | 0.88 |
| HPV replication | suppresses | process | 0.88 |
| RNA/DNA Helicase Activity | involved_in | process | 0.85 |
| DNA Damage Response | involved_in | process | 0.85 |
| Transcriptional Regulation | involved_in | process | 0.85 |
| R-loop | biomarker_for | biomarker | 0.85 |
| transcription | regulates | process | 0.85 |
| Autosomal Recessive Ataxia | causes | disease | 0.85 |
| Hpv Replication | regulates | process | 0.85 |
| Neurodegeneration | associated_with | disease | 0.85 |
| Dna Damage Response | involved_in | pathway | 0.85 |
| Haploinsufficiency | involved_in | mechanism | 0.80 |
| R-loop | regulates | biological_process | 0.80 |
| Transcriptional Regulation | regulates | process | 0.80 |
| autophagy regulation | functions_in | process | 0.80 |
| familial amyotrophic lateral sclerosis type 4 | implicated_in | disease | 0.80 |
| R-loop | binds | compound | 0.80 |
| RNA processing | regulates | process | 0.80 |
| R-loop_resolution | catalyzes | pathway | 0.80 |
| motor neuron | expressed_in | cell_type | 0.75 |
| ALS | causes | disease | 0.70 |
| oxidative stress response | participates_in | pathway | 0.70 |
| neurons | expressed_in | cell_type | 0.70 |
| neural stem cells | regulates | cell_type | 0.70 |
| Spinal Muscular Atrophy | associated_with | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Sirna Treatment | downregulates | drug | 0.95 |
| Sirna | targets | drug | 0.92 |
| Cell Differentiation | upregulates | process | 0.90 |
| h-c463d225 | targets_gene | hypothesis | 0.90 |
| siRNA | targets | drug | 0.85 |
| cell differentiation | upregulates | process | 0.85 |
| h-c463d225 | targets | hypothesis | 0.80 |
| RNA | accumulates_in | gene | 0.70 |
| XPG | activates | gene | 0.60 |
| ACTB | associated_with | gene | 0.60 |
| GABARAP | associated_with | gene | 0.60 |
| ULK1 | associated_with | gene | 0.60 |
| WIPI2 | associated_with | gene | 0.60 |
| LC3 | associated_with | gene | 0.60 |
| BECN1 | associated_with | gene | 0.60 |
| HTT | associated_with | gene | 0.60 |
| ATG7 | associated_with | gene | 0.60 |
| ALS4 | inhibits | gene | 0.60 |
| XPF | activates | gene | 0.60 |
| PNKP | activates | gene | 0.60 |
| TDP1 | activates | gene | 0.60 |
| FEN1 | activates | gene | 0.60 |
| SQSTM1 | associated_with | gene | 0.60 |
| SMN1 | associated_with | gene | 0.60 |
| DNMT1 | associated_with | gene | 0.60 |
| P62 | associated_with | gene | 0.60 |
| TFEB | associated_with | gene | 0.60 |
| ALS4 | associated_with | gene | 0.60 |
| ALS4 | regulates | gene | 0.60 |
| WFS1 | associated_with | gene | 0.60 |
| HARS | associated_with | gene | 0.60 |
| ATM | associated_with | gene | 0.60 |
| CLPP | associated_with | gene | 0.60 |
| XRCC1 | activates | gene | 0.60 |
| ALS4 | causes | entity | 0.60 |
| ACTB | activates | entity | 0.60 |
| ALS4 | activates | entity | 0.60 |
| ATG7 | activates | entity | 0.60 |
| BECN1 | activates | entity | 0.60 |
| DNMT1 | activates | entity | 0.60 |
| GABARAP | activates | entity | 0.60 |
| HTT | activates | entity | 0.60 |
| HUNTINGTIN | activates | entity | 0.60 |
| P62 | activates | entity | 0.60 |
| ALS4 | treats | entity | 0.60 |
| HUNTINGTIN | associated_with | gene | 0.60 |
| PNPLA6 | associated_with | gene | 0.60 |
| POLG | associated_with | gene | 0.60 |
| TWNK | associated_with | gene | 0.60 |
| LARS2 | associated_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| R-Loop Resolution Enhancement Therapy | 0.428 | neurodegeneration | RNA binding protein dysregulation across |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.490
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Allele-specific silencing of a dominant SETX mutation in familial amyotrophic la [PMID:40200577] | Winkelsas A, Apfel A, Johnson B, Harmiso | HGG Adv | 2025 | 1 |
| SETX (senataxin), the helicase mutated in AOA2 and ALS4, functions in autophagy [PMID:32686621] | Richard P, Feng S, Tsai YL, Li W, Rinche | Autophagy | 2021 | 1 |
| Dual Processing of R-Loops and Topoisomerase I Induces Transcription-Dependent D [PMID:31533039] | Cristini A, Ricci G, Britton S, Salimben | Cell Rep | 2019 | 1 |
| Molecular characterization of recessively inherited ataxic and neuropathic disor [PMID:41606223] | ["Aslam F", "Wajid M", "Butt A", "Wohler | Scientific reports | 2026 | 0 |
| Deciphering ALS-linked genetic variants in indian patients using targeted and ex [PMID:41137727] | ["Reza S", "Handique J", "Sharma P", "Ma | Amyotrophic lateral sclerosis | 2026 | 0 |
| Genetic commonalities between rare subtypes of ALS and CMT: insights into molecu [PMID:41621017] | Aynaashe A, Kursula P | Amino acids | 2026 | 0 |
| N(6)-methyladenosine modification of RNA is regulated by senataxin and E6 to con [PMID:41518615] | ["Templeton C", "Laimins L"] | Cell reports | 2026 | 0 |
| The SMC5/SMC6 complex is critical for resolving R-loop-induced transcription-rep [PMID:41533569] | Wu T, Li Y, Zhao Y, Bournique E, Ortega | Nucleic acids research | 2026 | 0 |
| Resolution of R-loops and transcription-replication conflicts by SETX-BRCA1-BARD [PMID:41917467] | Dutta A, Ji JH, Syed S, Fang Q, Mukhopad | Nature structural & molecular | 2026 | 0 |
| Ataxia and oculomotor apraxia caused by a large-scale deletion in the senataxin [PMID:40830689] | ["Rusecka J", "Kierdaszuk B", "St\u0119p | Journal of applied genetics | 2025 | 0 |
| Unraveling the genetic landscape of ALS in Greece: identification of known and n [PMID:41196070] | ["Kartanou C", "Kontogeorgiou Z", "Loupi | Amyotrophic lateral sclerosis | 2025 | 0 |
| Break-induced replication is activated to repair R-loop-associated double-strand [PMID:40475435] | ["Wu T", "Li Y", "Shi L", "Wu X"] | bioRxiv : the preprint server | 2025 | 0 |
| A role for human senataxin in contending with pausing and backtracking during tr [PMID:41232527] | Han Z, Fu S, Johansen JV, Lopez Martinez | Molecular cell | 2025 | 0 |
| Break-induced replication is activated to repair R-loop-associated double-strand [PMID:41037402] | Wu T, Li Y, Zhao Y, Shah SB, Shi LZ, Wu | Cell reports | 2025 | 0 |
| Unveiling ten novel SETX mutations: implications for ALS pathogenesis and clinic [PMID:40338003] | ["Chen X", "Chen X", "Lin X", "Zhou W", | Somatosensory & motor research | 2025 | 0 |
| ZPR1 Is Dispensable for HPV R-Loop Resolution but Regulates Host R-Loop Dynamics [PMID:41305523] | Moffitt R, Brooks S, Androphy EJ, DeSmet | Viruses | 2025 | 0 |
| Senataxin: A key actor in RNA metabolism, genome integrity and neurodegeneration [PMID:37558082] | ["Giannini M", "Porrua O"] | Biochimie | 2024 | 0 |
| Role of senataxin in R-loop-mediated neurodegeneration. [PMID:39070547] | Kannan A, Gangadharan Leela S, Branzei D | Brain communications | 2024 | 0 |
| Helicases in R-loop Formation and Resolution. [PMID:37778731] | Yang S, Winstone L, Mondal S, Wu Y | The Journal of biological chem | 2023 | 0 |
| R-loop-derived cytoplasmic RNA-DNA hybrids activate an immune response. [PMID:36544021] | Crossley MP, Song C, Bocek MJ, Choi JH, | Nature | 2023 | 0 |